EWA
KRON

EverSource Wealth Advisors’s Kronos Bio KRON Stock Holding History

EverSource Wealth Advisors’s Portfolio KRON Stock Details KRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-813
Closed -$1.06K – 2698
2023
Q3 		$1.06K Buy
+813
New +$1.31K ﹤0.01% 2183

Other funds holding KRON

OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCIG
Partners Capital Investment Group Boston, Massachusetts $2.83B AUM 20.31% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

EverSource Wealth Advisors's KRON Position: Q4 2023 in Review

EverSource Wealth Advisors sold out of Kronos Bio (KRON) in Q4 2023, closing a stake of 813 shares — an estimated $1.06K sold.

EverSource Wealth Advisors first reported a position in KRON in Q3 2023 and held it in 1 quarter. The position peaked at $1.06K in Q3 2023. 60 funds tracked by Wall St. Rank hold KRON as of Q4 2023.

  • EverSource Wealth Advisors reported no remaining Kronos Bio position as of Q4 2023 after selling out during the quarter.
  • EverSource Wealth Advisors sold 813 Kronos Bio shares in Q4 2023, an estimated $1.06K.
  • EverSource Wealth Advisors first reported a position in Kronos Bio in Q3 2023 and held it in 1 quarter.
  • EverSource Wealth Advisors's Kronos Bio position peaked at $1.06K in Q3 2023.
  • 60 funds tracked by Wall St. Rank held Kronos Bio as of Q4 2023.

Based on EverSource Wealth Advisors's 13F filing for Q4 2023, filed 9 Feb 2024.